Filing Details

Accession Number:
0000899243-19-014292
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-21 20:00:38
Reporting Period:
2019-05-18
Accepted Time:
2019-05-21 20:00:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1351288 Gw Pharmaceuticals Plc GWPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1754122 Volker Knappertz Sovereign House, Vision Park, Histon
Cambridge X0 CB24 9BZ
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2019-05-18 12,144 $0.00 97,968 No 4 M Direct
Ordinary Shares Disposition 2019-05-20 5,832 $14.52 92,136 No 4 S Direct
Ordinary Shares Disposition 2019-05-20 6,312 $14.76 85,824 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Restricted Stock Units Disposition 2019-05-18 12,144 $0.00 12,144 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-05-18 2019-05-18 No 4 M Direct
Footnotes
  1. Vesting of restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018. These ordinary shares are subsequently converted into American Depositary Shares ("ADS") of the Issuer.
  2. Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.27 U.S. Dollars as of May 17, 2019.
  3. Includes 49,632 and 27,456 ordinary shares underlying restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018 and Form 4 filed on March 5, 2019, respectively.
  4. Represented by ADSs.
  5. The price reported in Column 4 is price per ordinary share converted from price per ADS.
  6. The price reported in Column 4 is a weighted average price per ordinary share ($177.13 per ADS). These shares were sold in multiple transactions at prices ranging from $177.06 per ADS (or $14.76 per ordinary share) to $177.13 per ADS (or $14.76 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  7. The reporting person's Form 3 filed on October 1, 2018 contained stock options to purchase 12,144 ordinary shares vesting on May 18, 2019 and expiring on March 15, 2020. These securities are restricted stock units with a nominal exercise price and vest automatically upon vesting date.